• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性睡眠呼吸暂停综合征与慢性肾脏病的进展有关。

Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease.

机构信息

Department of Pulmonary Medicine, Erciyes University School of Medicine, Kayseri, Turkey.

出版信息

Int Urol Nephrol. 2012 Apr;44(2):535-9. doi: 10.1007/s11255-011-9927-8. Epub 2011 Mar 3.

DOI:10.1007/s11255-011-9927-8
PMID:21369754
Abstract

BACKGROUND AND AIM

Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for the development of cardiovascular events and hypertension. The possible causes are oxygen desaturation due to hypopnea, increased cytokine levels and insulin resistance. All these risk factors also have a role in the progression of chronic kidney disease (CKD). The aim of this study was to determine the relationship between OSAS and the severity of CKD.

MATERIALS AND METHODS

We retrospectively evaluated the medical records of 175 subjects who were admitted for the polysomnography study. OSAS was diagnosed by polysomnography if Apnea-Hypopnea Index (AHI) > 5 and glomerular filtration rate (GFR) was calculated with Cockcroft-Gault formula. According to AHI, individuals with AHI < 5 were recruited as group 1 (OSAS negative group), those with AHI = 5-15 group 2 (mild OSAS group), those with AHI = 15-30 group 3 (moderate OSAS group), and those with AHI > 30 group 4 (severe OSAS group).

RESULTS

Of the subjects, 117 (67%) were men, 58 (33%) were women and the mean age was 54.0 ± 12.1 years. There were 28 (14.3%), 18 (10.3%), 35 (20.0%) and 97 (55.4%) patients in groups 1, 2, 3 and 4 respectively. The prevalence of diabetes mellitus and hypertension and body mass index was significantly higher in severe OSAS group (P < 0.05). A significant decrease in GFR was detected when the severity of OSAS increased (group 1 = 50.0 ± 11.8, group 2 = 44.8 ± 15.9, group 3 = 40.8 ± 14.7, group 4 = 38.8 ± 16.0; P for trend < 0.001).

CONCLUSION

In the light of the present study, we speculate that OSAS is an independent risk factor for the progression of chronic kidney disease, which is a growing health problem. Further randomized-multicenter prospective studies are warranted to evaluate this relationship.

摘要

背景与目的

阻塞性睡眠呼吸暂停综合征(OSAS)是心血管事件和高血压发展的独立危险因素。可能的原因是呼吸暂停引起的氧饱和度下降、细胞因子水平升高和胰岛素抵抗。所有这些危险因素在慢性肾脏病(CKD)的进展中也起作用。本研究旨在确定 OSAS 与 CKD 严重程度之间的关系。

材料与方法

我们回顾性评估了 175 名因多导睡眠图研究而住院的患者的病历。如果呼吸暂停-低通气指数(AHI)> 5,则通过多导睡眠图诊断为 OSAS,肾小球滤过率(GFR)用 Cockcroft-Gault 公式计算。根据 AHI,将 AHI < 5 的个体纳入第 1 组(OSAS 阴性组),将 AHI = 5-15 的个体纳入第 2 组(轻度 OSAS 组),将 AHI = 15-30 的个体纳入第 3 组(中度 OSAS 组),将 AHI > 30 的个体纳入第 4 组(重度 OSAS 组)。

结果

在研究对象中,117 名(67%)为男性,58 名(33%)为女性,平均年龄为 54.0 ± 12.1 岁。第 1、2、3 和 4 组分别有 28(14.3%)、18(10.3%)、35(20.0%)和 97(55.4%)名患者。在重度 OSAS 组中,糖尿病和高血压的患病率以及体重指数显著升高(P < 0.05)。随着 OSAS 严重程度的增加,GFR 显著下降(第 1 组=50.0 ± 11.8,第 2 组=44.8 ± 15.9,第 3 组=40.8 ± 14.7,第 4 组=38.8 ± 16.0;趋势 P < 0.001)。

结论

根据本研究,我们推测 OSAS 是慢性肾脏病进展的独立危险因素,这是一个日益严重的健康问题。需要进一步进行随机、多中心的前瞻性研究来评估这种关系。

相似文献

1
Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease.阻塞性睡眠呼吸暂停综合征与慢性肾脏病的进展有关。
Int Urol Nephrol. 2012 Apr;44(2):535-9. doi: 10.1007/s11255-011-9927-8. Epub 2011 Mar 3.
2
Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.血清γ-谷氨酰转移酶活性是阻塞性睡眠呼吸暂停综合征患者心血管疾病的独立预测因子。
Respir Med. 2011 Apr;105(4):637-42. doi: 10.1016/j.rmed.2010.12.003. Epub 2010 Dec 23.
3
Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome.阻塞性睡眠呼吸暂停综合征患者血清γ-谷氨酰转移酶水平与心血管疾病相关。
Ann Saudi Med. 2013 Nov-Dec;33(6):584-90. doi: 10.5144/0256-4947.2013.584.
4
Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovascular diseases.阻塞性睡眠呼吸暂停综合征患者的平均血小板体积及其与心血管疾病的关系。
Blood Coagul Fibrinolysis. 2013 Jul;24(5):532-6. doi: 10.1097/MBC.0b013e32835e98da.
5
Gender differences on polysomnographic findings in Greek subjects with obstructive sleep apnea syndrome.希腊阻塞性睡眠呼吸暂停综合征患者多导睡眠图结果的性别差异。
Sleep Med. 2006 Aug;7(5):424-30. doi: 10.1016/j.sleep.2005.12.014. Epub 2006 Jun 5.
6
Usefulness of adenotonsillar size for prediction of severity of obstructive sleep apnea and flow limitation.腺样体扁桃体大小对阻塞性睡眠呼吸暂停严重程度及气流受限预测的作用。
Otolaryngol Head Neck Surg. 2013 Aug;149(2):326-34. doi: 10.1177/0194599813490892. Epub 2013 May 28.
7
Predictors of obstructive sleep apnea severity in adenotonsillectomy candidates.腺样体扁桃体切除术候选患者阻塞性睡眠呼吸暂停严重程度的预测因素。
Sleep. 2014 Feb 1;37(2):261-9. doi: 10.5665/sleep.3394.
8
[Relationship between the severity of obstructive sleep apnea and hypertension].阻塞性睡眠呼吸暂停严重程度与高血压之间的关系
Anadolu Kardiyol Derg. 2007 Dec;7(4):378-82.
9
Gamma-glutamyl transferase activity as a predictive marker for severity of obstructive sleep apnea syndrome and concomitant hypertension.γ-谷氨酰转移酶活性作为阻塞性睡眠呼吸暂停综合征严重程度及并发高血压的预测指标
Clin Respir J. 2018 May;12(5):1964-1973. doi: 10.1111/crj.12765. Epub 2018 Feb 12.
10
Obstructive sleep apnea severity correlates with cellular and plasma oxidative stress parameters and affective symptoms.阻塞性睡眠呼吸暂停严重程度与细胞和血浆氧化应激参数及情感症状相关。
J Mol Neurosci. 2012 Jun;47(2):300-10. doi: 10.1007/s12031-012-9738-0. Epub 2012 Mar 9.

引用本文的文献

1
Prevalence and impact of obstructive sleep apnea in type 2 diabetes mellitus: A descriptive cross-sectional study.2型糖尿病患者中阻塞性睡眠呼吸暂停的患病率及影响:一项描述性横断面研究。
Med J Armed Forces India. 2024 Dec;80(Suppl 1):S50-S56. doi: 10.1016/j.mjafi.2022.07.008. Epub 2022 Sep 29.
2
Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive Review.缺氧诱导的胰岛素抵抗介导阻塞性睡眠呼吸暂停患者心血管风险的升高:一项综述
Rev Cardiovasc Med. 2024 Jun 25;25(6):231. doi: 10.31083/j.rcm2506231. eCollection 2024 Jun.
3
Female obesity: clinical and psychological assessment toward the best treatment.

本文引用的文献

1
Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort.早期及晚期慢性肾脏病中的睡眠呼吸暂停:南加州凯撒医疗集团队列研究
Chest. 2009 Mar;135(3):710-716. doi: 10.1378/chest.08-2248. Epub 2008 Nov 24.
2
Prevalence of chronic kidney disease in the United States.美国慢性肾脏病的患病率。
JAMA. 2007 Nov 7;298(17):2038-47. doi: 10.1001/jama.298.17.2038.
3
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
女性肥胖:最佳治疗的临床和心理评估。
Front Endocrinol (Lausanne). 2024 May 3;15:1349794. doi: 10.3389/fendo.2024.1349794. eCollection 2024.
4
Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates.贫血和缺氧对慢性肾脏病发生及进展的影响:综述与更新
Cureus. 2023 Oct 9;15(10):e46737. doi: 10.7759/cureus.46737. eCollection 2023 Oct.
5
Obesity-related kidney disease: Beyond hypertension and insulin-resistance.肥胖相关性肾病:超越高血压和胰岛素抵抗。
Front Endocrinol (Lausanne). 2023 Jan 16;13:1095211. doi: 10.3389/fendo.2022.1095211. eCollection 2022.
6
Risk of chronic kidney disease in patients with obstructive sleep apnea.阻塞性睡眠呼吸暂停患者的慢性肾脏病风险。
Sleep. 2022 Feb 14;45(2). doi: 10.1093/sleep/zsab267.
7
Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis.格列净类药物在 OSA 和 T2DM 中的可能预防/康复作用。基于系统文献回顾的假说。
Adv Ther. 2021 Aug;38(8):4195-4214. doi: 10.1007/s12325-021-01791-x. Epub 2021 Jul 17.
8
Continuous Positive Airway Pressure Improves Renal Function in Obese Patients With Obstructive Sleep Apnea Syndrome.持续气道正压通气改善肥胖阻塞性睡眠呼吸暂停低通气综合征患者的肾功能
Front Med (Lausanne). 2021 Mar 3;8:642086. doi: 10.3389/fmed.2021.642086. eCollection 2021.
9
Obstructive sleep apnea syndrome and risk of renal impairment: a systematic review and meta-analysis with trial sequential analysis.阻塞性睡眠呼吸暂停综合征与肾功能损害风险:系统评价和荟萃分析及试验序贯分析。
Sleep Breath. 2021 Mar;25(1):17-27. doi: 10.1007/s11325-020-02090-5. Epub 2020 May 21.
10
Glomerular filtration rate in patients with obstructive sleep apnea: the influence of cystatin-C-based estimations and comorbidity.阻塞性睡眠呼吸暂停患者的肾小球滤过率:基于胱抑素-C评估及合并症的影响
J Thorac Dis. 2020 Mar;12(3):175-183. doi: 10.21037/jtd.2020.02.11.
2007年动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组制定
J Hypertens. 2007 Jun;25(6):1105-87. doi: 10.1097/HJH.0b013e3281fc975a.
4
Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease.睡眠呼吸暂停和终末期肾病患者化疗反应性增强。
Eur Respir J. 2006 Jul;28(1):151-8. doi: 10.1183/09031936.06.00075405. Epub 2006 Mar 1.
5
[Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis].[阻塞性睡眠呼吸暂停综合征、内皮功能障碍与冠状动脉粥样硬化]
Tuberk Toraks. 2005;53(3):299-306.
6
Oxidative stress in obstructive sleep apnea.阻塞性睡眠呼吸暂停中的氧化应激
Chest. 2005 May;127(5):1674-9. doi: 10.1378/chest.127.5.1674.
7
Relationship among end-stage renal disease, hypertension, and sleep apnea in nondiabetic dialysis patients.非糖尿病透析患者终末期肾病、高血压与睡眠呼吸暂停之间的关系。
Am J Hypertens. 2005 Feb;18(2 Pt 1):152-7. doi: 10.1016/j.amjhyper.2004.08.028.
8
Obesity: an endocrine tumor?肥胖:一种内分泌肿瘤?
Med Hypotheses. 2004;63(5):790-2. doi: 10.1016/j.mehy.2004.01.046.
9
Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia.阻塞性睡眠呼吸暂停和严重夜间低氧血症患者的血清血管内皮生长因子水平升高。
Am J Respir Crit Care Med. 2002 Jan 1;165(1):67-70. doi: 10.1164/ajrccm.165.1.2101062.
10
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin.体重减轻会增加一种脂肪来源的抗炎蛋白——脂联素的血浆水平。
J Clin Endocrinol Metab. 2001 Aug;86(8):3815-9. doi: 10.1210/jcem.86.8.7741.